You are here

nDatalyze Corp.

nDatalyze Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NDAT
CSE Index: 
Currency: 

nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application and the database sales division is focusing on providing a specialized health-related Reference Database to application developers and researchers. YMI is based on the Corporation's proprietary Reference Database consisting of >1200 biometric records complete with electroencephalogram ("EEG") "same-time-of-day" data. With installations worldwide, it's Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development and accordingly the Corporation cannot accurately predict if or when this application will become a cash flow generator. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.

You are here

nDatalyze Corp. (NDAT)

SEDAR Information

Company Info

Address
1150, 707 - 7 Avenue SW
Calgary, AB T2P 3H6
Canada
Phone
403-689-3901
Email
jimd@ndatalyze.com
Website
https://www.ndatalyze.com
Listing date
Thursday, October 24, 2019
Transfer Agent
TSX Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
38,722,425
Reserved for Issuance: 
1,571,380

News Releases

Bulletins

20/10/2021

2021-1022 – Name and Symbol Change - MedXtracator Corp. (MXT)

le 20 octobre/October 2021

MedXtracator Corp. has announced a name and symbol change to nDatalyze Corp. (NDAT)

Shares will begin trading under the new name, symbol and with a new CUSIP number on October 22, 2021.

Disclosure documents are available at www.thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

Website_2.jpg

Capital Markets Comeback Tour

Wednesday, May 11, 2022 to Thursday, June 2, 2022